Literature DB >> 12338632

Subdermal levonorgestrel implants: serum androgens.

M I Osman, M I Abdalla, M H Toppozada, M A Bayad, I I Ibrahim, E Z Hafez.   

Abstract

Serum levels of androstenedione, dihydrotestosterone, and testosterone were determined by radioimmunoassay procedures in 25 female volunteers using subdermal levonorgestrel implants as a contraceptive. Mean serum androstenedione levels were increased after 1 and 6 months in comparison with preimplantation levels, the increase being significant only after 1 month. This could be attributed to increased production from the adrenal or ovaries and/or changes in clearance rate. Testosterone levels showed approximately 24% increase above basal values after 6 months' use of levonorgestrel implants, which was attributed to concomitant increases in androstenedione levels. The implication of these results is discussed.

Entities:  

Keywords:  Age Factors; Androgens--analysis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Agents--administraction and dosage; Contraceptive Methods; Endocrine System; Family Planning; Hormones; Injectables; Levonorgestrel--administraction and dosage; Parity; Physiology; Reproductive Control Agents; Testosterone

Mesh:

Substances:

Year:  1983        PMID: 12338632

Source DB:  PubMed          Journal:  Contracept Deliv Syst        ISSN: 0143-6112


  2 in total

1.  Facts about an implantable contraceptive: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

2.  [Concerning an implantable contraceptive: a memorandum of a WHO meeting].

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.